摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(+)-2-O-苄基-L-苏糖醇 | 84379-51-1

中文名称
(+)-2-O-苄基-L-苏糖醇
中文别名
——
英文名称
(2R,3R)-(-) 2-benzyloxy 1,3,4- butanetriol
英文别名
3-Phenylmethoxybutane-1,2,4-triol
(+)-2-O-苄基-L-苏糖醇化学式
CAS
84379-51-1
化学式
C11H16O4
mdl
MFCD24390208
分子量
212.246
InChiKey
YYGZBCNOJHZTGA-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    75-77 °C
  • 沸点:
    424.1±40.0 °C(Predicted)
  • 密度:
    1.238±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    -0.3
  • 重原子数:
    15
  • 可旋转键数:
    6
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.454
  • 拓扑面积:
    69.9
  • 氢给体数:
    3
  • 氢受体数:
    4

安全信息

  • 危险品标志:
    Xi
  • 安全说明:
    S26,S36/37
  • 危险类别码:
    R36

SDS

SDS:0f5a195737292c305ce5fcaa6f09c228
查看

反应信息

  • 作为反应物:
    描述:
    (+)-2-O-苄基-L-苏糖醇 生成 [2-(2,2-dimethyl-1,3-dioxolan-4-yl)-2-phenylmethoxyethyl] methanesulfonate
    参考文献:
    名称:
    MIYAZAKI, HIDEKI;OHKAWA, NOBUYUKI;NAKAMURA, NORIO;ITO, TOMIYOSHI;SADA, TO+, CHEM. AND PHARM. BULL., 37,(1989) N, C. 2379-2390
    摘要:
    DOI:
  • 作为产物:
    描述:
    参考文献:
    名称:
    MIYAZAKI, HIDEKI;OHKAWA, NOBUYUKI;NAKAMURA, NORIO;ITO, TOMIYOSHI;SADA, TO+, CHEM. AND PHARM. BULL., 37,(1989) N, C. 2379-2390
    摘要:
    DOI:
点击查看最新优质反应信息

文献信息

  • Towards applications in catalysis: investigation on photocatalytic activities of a derivative family of the Keplerate type molybdenum–oxide based polyoxometalates
    作者:Yunshan Zhou、Libo Qin、Chao Yu、Tian Xiong、Lijuan Zhang、Waqar Ahmad、Hao Han
    DOI:10.1039/c4ra07700h
    日期:——

    The photocatalytic potential of a derivative family of the unique Keplerate type nanoporous Mo–O based polyoxometalates has been evaluated.

    这句话的中文翻译为:“已经评估了独特的Keplerate型纳米多孔Mo-O基聚酸金属衍生物家族的光催化潜力。”
  • 8-ARM POLYETHYLENE GLYCOL DERIVATIVE, MANUFACTURING METHOD AND MODIFIED BIO-RELATED SUBSTANCE THEREBY
    申请人:Xiamen Sinopeg Biotech Co., Ltd.
    公开号:EP3315531A1
    公开(公告)日:2018-05-02
    Disclosed are an 8-arm polyethylene glycol (PEG) derivative (formula 1), manufacturing method and modified bio-related substance thereby, wherein a tetravalent group U and four trivalent groups Ec form a highly symmetric octavalent central structure CORE0 together, Lc connects the octavalent center to eight PEG arms having polydiversity or monodiversity and having n1-n8 as the degrees of polymerization thereof. The terminal of one PEG chain is connected to at least one functional group F (k ≥ 1), and said PEG chain and F can be directly connected (g = 0) or connected with a divalent linking group L0 connected with a terminal branched group G (g = 1) therebetween. The latter provides more reacting sites to combine more pharmaceutical molecules, thereby increasing the drug loading capacity. The near-center symmetric structure of the derivative allows more precise control over the molecular weight during large-scale production, thereby facilitating acquisition of a product having a narrower molecular weight distribution. A bio-related substance modified thereby has a more uniform and controllable performance.
    本发明公开了一种 8 臂聚乙二醇(PEG)衍生物(式 1)、其制造方法和改性生物相关物质,其中一个四价基团 U 和四个三价基团 Ec 共同形成一个高度对称的八价中心结构 CORE0,Lc 将八价中心连接到八个 PEG 臂上,这些 PEG 臂具有多元性或单元性,其聚合度为 n1-n8。一条 PEG 链的末端与至少一个官能团 F(k ≥ 1)相连,所述 PEG 链和 F 可以直接相连(g = 0),也可以通过二价连接基 L0 与中间的末端支化基 G(g = 1)相连。后者提供了更多的反应位点,可以结合更多的药物分子,从而提高药物负载能力。衍生物的近中心对称结构可以在大规模生产过程中更精确地控制分子量,从而有利于获得分子量分布更窄的产品。由此改性的生物相关物质具有更均匀、更可控的性能。
  • EP300/CREBBP INHIBITOR
    申请人:Daiichi Sankyo Co., Ltd.
    公开号:EP3643703A1
    公开(公告)日:2020-04-29
    The present invention provides a compound having excellent histone acetyltransferase inhibitory activity against EP300 and/or CREBBP, or a pharmacologically acceptable salt thereof. The compound is represented by the following formula (1) or a pharmacologically acceptable salt thereof: wherein ring Q1, ring Q2, R1, R2, R3 and R4 respectively have the same meanings as defined in the specification.
    本发明提供了一种对 EP300 和/或 CREBBP 具有优异组蛋白乙酰转移酶抑制活性的化合物或其药理学上可接受的盐。该化合物由下式(1)或其药理学上可接受的盐表示: 其中,环 Q1、环 Q2、R1、R2、R3 和 R4 分别具有本说明书中定义的相同含义。
  • Eight-arm polyethylene glycol derivative, production method therefor, and modified bio-related substance thereof
    申请人:XIAMEN SINOPEG BIOTECH CO., LTD.
    公开号:US10434182B2
    公开(公告)日:2019-10-08
    Disclosed are an eight-arm polyethylene glycol (PEG) derivative (formula I), production method therefor and modified bio-related substance thereby. Wherein, one tetravalent group U together with four trivalent groups Ec form a highly symmetrical octavalent group CORE0; Lc connects the octavalent group to eight PEG chains having polydispersity or monodispersity and having n1 to n8 as the degree of polymerization thereof; the terminal of one PEG chain is connected to at least one functional group F (k≥1); said PEG chain and F therebetween can be directly connected (g=0) or be indirectly connected via a linking group L0 to a terminal end-branching group G (g=1); the latter provides more reactive sites for binding more drug molecules and increases the drug loading. The eight-arm polyethylene glycol derivative has a centrosymmetric or approximately centrosymmetric structure, and leads to more precise control of the molecular weight in large-scale production and much narrower distribution of molecular weight for products. The modified bio-related substance thereby has a more uniform and controllable performance.
    本发明公开了一种八臂聚乙二醇(PEG)衍生物(式 I)、其生产方法及其改性生物相关物质。其中,一个四价基团 U 与四个三价基团 Ec 形成一个高度对称的八价基团 CORE0;Lc 将八价基团连接到八条具有多分散性或单分散性且聚合度为 n1 至 n8 的 PEG 链上;一条 PEG 链的末端与至少一个官能团 F 连接(k≥1);所述 PEG 链和 F 之间可以直接连接(g=0),也可以通过连接基团 L0 与末端支化基团 G 间接连接(g=1);后者提供了更多的反应位点,可以结合更多的药物分子,增加药物负载量。八臂聚乙二醇衍生物具有中心对称或近似中心对称结构,因此在大规模生产中可以更精确地控制分子量,产品的分子量分布也更窄。因此,改性生物相关物质的性能更均匀、更可控。
  • Multifunctionalized polyethylene glycol derivative and preparation method therefor
    申请人:XIAMEN SINOPEG BIOTECH CO., LTD.
    公开号:US11324827B2
    公开(公告)日:2022-05-10
    Disclosed are a multifunctionalized polyethylene glycol derivative and a preparation method therefor. The derivative has an H-shaped structure as represented by formula (1) and comprises one linear core LPEG and four PEG branch chains, where n1, n2, n3, and n4 respectively are the degrees of polymerization of the branch chains, U1 and U2 are trivalent branching groups connecting the core LPEG to two of the PEG branch chains, F1 and F2 contain a functional group or a protected form R01 thereof and may or may not contain a branched group G, correspondingly, the number of R01 is one or more, F1 and F2 are either identical or different, any one linking group in the molecule or any linking group formed with an adjacent heteroatom group can either remain stable or be degraded, and any one PEG segment in the molecule is discretely polydispersed or monodispersed. The multifunctional polyethylene glycol is flexible and diverse in terms of branch structures and the lengths of branching arms, has various parameters and performance indicators that are adjustable and easy to control, and has a broad applicability.
    本发明公开了一种多功能聚乙二醇衍生物及其制备方法。该衍生物具有由式(1)表示的 H 型结构,包括一个线性核心 LPEG 和四个 PEG 支链,其中 n1、n2、n3 和 n4 分别为支链的聚合度,U1 和 U2 为连接核心 LPEG 和两个 PEG 支链的三价支化基团、F1 和 F2 含有一个官能团或其保护形式 R01,可以含有或不含有支链基团 G,相应地,R01 的数目为一个或多个,F1 和 F2 要么相同要么不同,分子中的任何一个连接基团或与相邻杂原子基团形成的任何连接基团要么保持稳定,要么降解,分子中的任何一个 PEG 段离散多分散或单分散。多功能聚乙二醇的支链结构和支臂长度灵活多样,各种参数和性能指标可调且易于控制,具有广泛的适用性。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐